Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy

Overview of attention for article published in BMC Cancer, February 2008

Altmetric Badge

Citations

dimensions_citation: 73 Dimensions

Readers on

mendeley: 58 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

Summary Dimensions citations

So far, Dimensions has found 73 publications that cite this research output.

73

The most recent citing publications are shown below. View all 73 publications that cite this research output on Dimensions.

Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?

Article in Breast Cancer Research and Treatment (January 2024)

Neoadjuvant endocrine therapy in ER-positive breast cancer: evolution, indication, and tailored treatment strategy

Article in Therapeutic Advances in Medical Oncology (January 2023)

The effect of prolonged neoadjuvant endocrine therapy on the efficacy of treatment with breast cancer.

Article in Technology and Health Care (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.